Cargando…
Current assessment practices for noncancer end points.
The need for assessing noncancer risks for agents to which humans are routinely exposed indoors arises from the large amount of time spent indoors (i.e., employed persons spend about 60% of their time at home indoors, 30% at work indoors, and 5% in transit). Sources of air pollutants include heating...
Autor principal: | Shoaf, C R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
1991
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1568395/ https://www.ncbi.nlm.nih.gov/pubmed/1821364 |
Ejemplares similares
-
Risk characterization framework for noncancer end points.
por: Pierson, T K, et al.
Publicado: (1991) -
Building on Success: Assessment Categories for Experimental Noncancer End Points
por: Weinhold, Bob
Publicado: (2009) -
Current Developments in Intraspinal Agents for Cancer and Noncancer Pain
por: Lawson, Erin F., et al.
Publicado: (2010) -
European clinical practice recommendations on opioids for chronic noncancer pain – Part 1: Role of opioids in the management of chronic noncancer pain
por: Häuser, Winfried, et al.
Publicado: (2021) -
Evaluating noncancer effects of trichloroethylene: dosimetry, mode of action, and risk assessment.
por: Barton, H A, et al.
Publicado: (2000)